Hypertensive emergency: Difference between revisions
No edit summary |
|||
| Line 38: | Line 38: | ||
| Nitroprusside | | Nitroprusside | ||
| | | | ||
0.3-0.5 mcg/kg/min IV initial infusion | |||
Incr by 0.5mcg/kg/min up to 2mcg/kg/min | |||
| Arterial and veno-dilator | | Arterial and veno-dilator | ||
| Line 64: | Line 66: | ||
|- | |- | ||
| Nitgroglycerin | | Nitgroglycerin | ||
| 5-100 mcg/min | | Start 5-100 mcg/min | ||
| Veno>arteriodilation | | Veno>arteriodilation | ||
| | | | ||
| Line 82: | Line 84: | ||
20-80mg IV bolus q10min OR | 20-80mg IV bolus q10min OR | ||
0.5-2mg/min IV | 0.5-2mg/min IV infusion | ||
| Beta>alpha blocker | | Beta>alpha blocker | ||
| Line 103: | Line 105: | ||
| Esmolol | | Esmolol | ||
| | | | ||
250-500 | Load 250-500 mg/kg/ over 2min | ||
Infuse 50mcg/kg/min over 4min | |||
- if ineffective repeat load, increase infusion rate by 50mcg/kg/min up to 200mcg/kg/min | |||
| Beta selective | | Beta selective | ||
| Line 121: | Line 123: | ||
|- | |- | ||
| Nicardipine | | Nicardipine | ||
| | | | ||
Start 5mg/h | |||
If ineffective after 15min incr in 2.5mg/hr interval up to 15mg/hr | |||
| Decreases PVR<br/><br/> | | Decreases PVR<br/><br/> | ||
| Good for intracranial pathology | | Good for intracranial pathology | ||
| Slower onset/offset | | Slower onset/offset | ||
| Avoid in CHF, ACS | | Avoid in CHF, ACS | ||
|- | |- | ||
| Phentolamine | | Phentolamine | ||
| Line 145: | Line 144: | ||
| Used for catecholamine-induced HTN | | Used for catecholamine-induced HTN | ||
|- | |- | ||
| | | Enalaprilat | ||
| 1.25mg over 5min q6hr | | Bolus 1.25mg over 5min q6hr, titrate at 30min intervals to max of 5mg q6hr | ||
| Decreases HR, SV, systemic arterial pressure | | Decreases HR, SV, systemic arterial pressure | ||
| Does not impair cerebral flow | | Does not impair cerebral flow | ||
Revision as of 22:31, 22 May 2011
Diagnosis
- End-organ damage 2/2 increased BP (generally >180/120, usually > 220/130)
- Brain - Encephalopathy, seizure, ICH, ischemic stroke
- Eyes - Retinal hemorrhage, exudate, papilledema
- Heart - ACS, CHF/LV failure/pulm edema
- Aorta - Dissection
- Renal - Acute failure, hematuria, proteinuria
- Ancillary Tests
- Chemistry - assess renal failure
- UA - Assess renal failure, glomerulonephritis, preeclampsia
- Troponin
- CXR - Evidence of failure, dissection
- ECG
Etiology
- Idiopathic
- Sympathomimetic drug use
- Preeclampsia
- Acute glomerulonephritis
Treatment
- Goal: Lower diastolic pressure to 105mmHg within 2-6 hours
- Maximum initial fall in BP should not exceed 25% of presenting value
- Be careful of lowering BP in pts with CVA
| Drug | Dose | Mechanism | Pros | Cons | Notes |
| Nitroprusside |
0.3-0.5 mcg/kg/min IV initial infusion Incr by 0.5mcg/kg/min up to 2mcg/kg/min
|
Arterial and veno-dilator |
1. Very effective 2. Immediate onset/offset |
1. Cyanide Toxicity 2. Coronary steal? 3. Incr HR |
1. Avoid in liver/renal failure 2. Avoid with incr ICP 3. Avoid in pregnancy |
| Nitgroglycerin | Start 5-100 mcg/min | Veno>arteriodilation |
1. Rapid on/offset 2. Increases coronary flow |
Causes Tachycardia |
Drug of choice in pts w/ cardiac ischemia, LV dysfunction, or pulm edema |
| Labetalol |
20-80mg IV bolus q10min OR 0.5-2mg/min IV infusion |
Beta>alpha blocker |
1. No change in HR, cerebral flow 2. Rapid onset |
Avoid in COPD, CHF heart block |
1. Consider in ACS 2. Consider in ischemic CVA |
| Esmolol |
Load 250-500 mg/kg/ over 2min Infuse 50mcg/kg/min over 4min - if ineffective repeat load, increase infusion rate by 50mcg/kg/min up to 200mcg/kg/min |
Beta selective | 1. Rapid on/offset |
Avoid in COPD, CHF bradycardia |
Consider in ACS |
| Nicardipine |
Start 5mg/h If ineffective after 15min incr in 2.5mg/hr interval up to 15mg/hr |
Decreases PVR |
Good for intracranial pathology | Slower onset/offset | Avoid in CHF, ACS |
| Phentolamine |
5-10mg IV bolus q5-15min OR 0.2-5mg/min IV infusion |
Alpha blocker | Used for catecholamine-induced HTN | ||
| Enalaprilat | Bolus 1.25mg over 5min q6hr, titrate at 30min intervals to max of 5mg q6hr | Decreases HR, SV, systemic arterial pressure | Does not impair cerebral flow | Variable response |
1. Used in pts at risk for cerebral hypotension, CHF 2. Avoid in pregnancy |
Disease Specific
Aortic Dissection
- Rapidly reduce sys BP to 100-120; HR 60-80 within 20min
- Avoid volume depletion
- Prevent reflex tachycardia
- Nitroprusside or nicardipine AFTER MTP or esmolol
- Labetolol alone
Pulmonary Edema
- Reduce BP by 20-30%
- Promote diuresis AFTER vasodilation
- See Pulmonary Edema
ACS
- No more than 20-30% reduction for SBP >160
- Consider NTG, B-blocker
Cocaine/Amphetamine Toxicitiy
- Benzos
- Mixed alpha + B blockade
- Phentolamine OR nitroprusside AND beta blocker
Renal Failure
- Reduce BP by no more than 20%
- Avoid nitroprusside (renal metabolism)
- Labetalol or nicardipine
Eclampsia/Pre-eclampsia
- Goal BP <160/110
- Labetalol or nicardipine
- Magnesium
Encephalopathy
- Decrease MAP by 15-20%
- Avoid overly aggressive lowering
- Nicardipine or labetalol
CVA
- SAH
- ICH
- If e/o incr ICP: target MAP = 130
- If no e/o incr ICP: target MAP = 110
- Labetalol or nicardipine or esmolol
- Ischemic
- If fibrinolytic tx planned, tx if >185-110
- If not planned, tx if >220-120
- Labetalol or NTG or nicardipine
Pheochromocytoma
- Phentolamine OR nitroprusside AND beta blocker
Source
Tintinalli
UpToDate
